Treść książki
Przejdź do opcji czytnikaPrzejdź do nawigacjiPrzejdź do informacjiPrzejdź do stopki
latureofIgG4-relateddiseaseanditsindivi-
dualorgansystemmanifestations.Arthritis
Rheum.2012;64:3061-3067.
10.MaritatiF.,PeyronelF.,VaglioA.:IgG4-
-relateddisease:aclinicalperspective.
Rheumatology(Oxford).2020;59(Suppl.3):
iii123-iii131.
11.JapanesestudygroupofIgG4-relatedoph-
thalmicdisease.AprevalencestudyofIgG4-
-relatedophthalmicdiseaseinJapan.JpnJ
Ophthalmol.2013;57:573-579.
12.AndrewN.H.,SladdenN.,KearneyD.J.
iwsp.AnanalysisofIgG4-relateddisease
(IgG4-RD)amongidiopathicorbitalinflam-
mationsandbenignlymphoidhyperplasias
usingtwoconsensus-baseddiagnosticcri-
teriaforIgG4-RD.BrJOphthalmol.2015;
99:376-381.
13.GontarzM.,Wyszyńska-PawelecG.,Zapała
J.IgG4-relateddiseaseoftheheadandneck.
JStoma.2017;70:76-87.
14.McNabA.A.,McKelvieP.IgG4-related
ophthalmicdisease.PartI:backgroundand
pathology.OphthalmicPlastReconstrSurg.
2015;31:83-88.
15.WallaceZ.S.,DeshpandeV.,StoneJ.H.
OphthalmicmanifestationsofIgG4-related
disease:single-centerexperienceandlitera-
turereview.SeminArthritisRheum.2014;
43:806-817.
16.StoneJ.H.,ZenY.,DeshpandeV
.IgG4-
-relateddisease.NEnglJMed.2012;366:
539-551.
17.EbboM.,GradosA.,GuedjE.iwsp.Useful-
nessof2-[18F]-fluoro-2-deoxy-D-glucose-
-positronemissiontomographylcomputed
tomographyforstagingandevaluationof
treatmentresponseinIgG4-relateddisease:
aretrospectivemulticenterstudy.Arthritis
CareRes(Hoboken).2014;66:86-96.
18.DeshpandeV
.,ZenY.,ChanJ.K.iwsp.
Consensusstatementonthepathologyof
IgG4-relateddisease.ModPathol.2012;25:
1181-1192.
19.ZenY.,NakanumaY
.IgG4-relateddisease:
across-sectionalstudyof114cases.AmJ
SurgPathol2010;34:1812-1819.
20.UmeharaH.,OkazakiK.,MasakiY
.iwsp.
ComprehensivediagnosticcriteriaforIgG4-
-relateddisease(IgG4-RD).ModRheuma-
tol.2012;22:21-30.
21.AndrewN.,KearneyD.,SelvaD.IgG4-
-relatedorbitaldisease:ameta-analysisand
review.ActaOphthalmol.2013;91:694-700.
22.HeadacheClassificationCommitteeofthe
InternationalHeadacheSociety(HIS)me
InternationalClassificationofHeadache
Disorders,Cephalalgia.2018;38:1-211.doi:
10.1177l0333102417738202.
23.LueckC.J.TimetoretiretheTolosa-Hunt
syndrome?PractNeurol.2018;18:350-351.
24.llenE.,RutlandJ.W
.,GreenM.W
.iwsp.
ReappraisingtheTolosa-HuntSyndrome
diagnosticcriteria:acaseseries.Headache
2020;60:259-264.
Piśmiennictwo
15
